News
Lawxpart/New
Kerry Killinger discusses Washington Mutual failure in rare public appearance
Killinger discussed for the first time in recent memory how he tried to prepare Washington Mutual for the financial crisis. He also talked about opportunities and risks for the banking industry and briefly mentioned the work he’s been doing since 2008.
Alaska Air sees uptick in passengers after tweaking flight routes
In July, the airline vowed to drop underperforming routes and add new ones to boost revenue and lower overhead.
The Funded: Two big shutdowns, 3 IPO filings and a Walmart acquisition
A pair of high-profile, venture-backed companies from San Francisco have shut down in recent days. Path Inc., a mobile social networking company founded by former Facebook product manager Dave Morin and ex-Napster founders Dustin Mierau and Shawn Fanning, announced its end on Monday. The original idea was to limit each user to to just 50 friends and provide a more private alternative to Facebook. The friend restriction was later removed and the service peaked at around 15 million users with…
Heidi Fleiss wants Amazon to let parrots live in the Spheres
The so-called “Hollywood madam” has a request for Amazon – let rescued parrots live in the company’s “urban jungle” in downtown Seattle.
Ex-Voya CEO joins Bellevue-based cannabis investor group’s advisory board
Maliz Beams is joining the board of the company cofounded by Ed Harris, a former senior member at Paul Allen’s Vulcan Ventures. Cannabis Investment Network is developing an online platform to connect marijuana entrepreneurs and investors.
This cancer-fighting biotech sped from startup to IPO filing in 10 months
The team that took Kite Pharma from a startup re-engineering a patient’s own cells to fight cancer to a $12 billion buyout now is seeking a $100 million initial public offering for the South San Francisco company it launched only 10 months ago. Arie Belldegrun and David Chang co-founded Allogene Therapeutics Inc. to develop off-the-shelf cells derived from healthy donors that could be used in a variety of cancer patients. And in moving quickly, Allogene has relied on friends in key places, including…

Call us Free
If you would like to speak with someone directly